Central Trust CO Amicus Therapeutics, Inc. Transaction History

Central Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$8.71 - $10.72 $1,567 - $1,929	-180 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$9.2 - $23.86 $276 - $715	30 Added 20.0%	180 $1,000
Q4 2020 Jan 29, 2021	SELL	$13.47 - $24.89 $134 - $248	-10 Reduced 6.25%	150 $3,000
Q3 2020 Oct 22, 2020	BUY	$12.89 - $15.89 $2,062 - $2,542	160 New	160 $2,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.77B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.